Digital Pathology News
Learn about the exciting new features in the 4.2 versions of HALO, HALO AI, and HALO Link! Intro to HALO®, HALO AI, and HALO Link 4.2 Date: 18 September 2025 Time: 8:00 – 9:00 PDT | 11:00 – 12:00 EDT | 16:00 –...
Lumea, the U.S. leader in primary clinical digital pathology, is proud to announce it has received four prestigious awards this fall, recognizing the company's rapid growth and transformative impact on cancer diagnostics. Lumea was named to the...
Pathomation and Mindpeak: Mindpeak’s CE-IVD certified algorithms are now fully integrated and operational within Pathomation’s trusted digital pathology platform, built for interoperability and control, enabling frictionless AI adoption in...
Dr. Lal PathLabs: It accurately detected single-cell and micrometastases that had been missed during manual reviews. Results were later validated through IHC, confirming the system’s reliability Dr. Lal PathLabs (DLPL) has adopted a deep...
The latest from the Proscia blog Emerging biotechs, along with their small and mid-sized CRO counterparts, are establishing themselves as key players advancing the next generation of therapies. So, in line with our mission to rewire...
OREM, Utah--(BUSINESS WIRE)--Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced that its platform, Techcyte Fusion™ (research use only (RUO) in the US, CE-IVDD-marked in...
